77 results
424B5
KA
Kineta Inc
5 Oct 23
Prospectus supplement for primary offering
10:47am
specific written approval of its customer.
DESCRIPTION OF CAPITAL STOCK
We are authorized to issue 125,000,000 shares of common stock, par value $0.001 … will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts of customers in bearer form
8-K
EX-99.1
ct18wz224rcsy288w
24 May 23
Regulation FD Disclosure
9:30am
424B5
a1g4iy qw
21 Apr 23
Prospectus supplement for primary offering
5:14pm
8-K
EX-10.6
dej3p6e5 ypmbg4d039
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.4
d0gh8v 9f
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.2
ywqahwy
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
ps7ztvb
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
48umbcjw5rj
10 Nov 22
Prospectus supplement
4:21pm